Medical Articles

From Gut Health to Overall Wellbeing: Why Digestive Disorders Matter More Than You Think

By Pedro Matos Rosa, Managing Director Johnson & Johnson Innovative Medicine GULF

 

When people think about health, they often picture the heart, lungs, or brain. But in recent years, science has turned its gaze inward to the gut. Frequently described as the body’s “second brain”, the digestive system does far more than break down food. It plays a profound role in regulating immunity, mood, and overall well-being¹.

Disruptions in gut health are increasingly linked to chronic conditions such as inflammatory bowel disease (IBD), a group of disorders that includes Crohn’s disease and ulcerative colitis². Affecting more than 10 million people globally³, IBD is characterized by chronic inflammation of the gastrointestinal tract, causing symptoms including abdominal pain, rectal bleeding, weight loss, and fatigue that can be painful and unpredictable⁴.

Recognizing this, the UAE has set its sights not only on tackling today’s health challenges but also on preparing for those of tomorrow, with increasing attention on chronic conditions such as inflammatory bowel disease (IBD), which are beginning to shape clinical priorities and public health conversations across the country.

In the UAE, the exact prevalence of IBD is not well established, but clinical data suggest the burden of disease is increasing, with diagnosis rising nearly 13-fold over the past two decades⁵. The onset of IBD can occur at any age, but it is most often diagnosed in adolescents and adults between the ages of 20 and 30⁶. 

For many patients, IBD is an invisible illness. Outwardly, they may look healthy, but inside, they are coping with urgent trips to the bathroom, severe abdominal pain, or fatigue that makes daily life unpredictable. The stigma of discussing bowel symptoms often compounds the challenge, causing some to delay seeking medical advice until the disease has already advanced.

Experts warn that this silence can be costly, not only for individuals but also for the healthcare system. Late diagnosis often means more complex treatment, higher costs, and a greater chance of complications such as strictures or the need for surgery.

Over the past decade, however, treatment for IBD has begun to evolve. Instead of simply managing flare-ups, doctors are now aiming for what’s called endoscopic healing – meaning the lining of the intestine shows no signs of ulcers or inflammation during a colonoscopy. Studies continue to show that patients who achieve endoscopic healing are more likely to experience improved long-term outcomes, including sustained remission and a reduced risk of hospitalization or surgery⁷. Put simply, when the gut looks healthy on the inside, patients are far more likely to stay well, avoid surgery, and enjoy a better quality of life.

Explaining this shift, Experts highlighted that: “Colonoscopy remains an important tool in the diagnosis and monitoring of IBD. But today, we don’t just use it to detect disease; we use it to measure progress. If a scope shows that inflammation has healed, what we call endoscopic healing, patients are far more likely to stay in remission, avoid hospitalization, and live fuller lives. With evolving awareness and better technology, we are consistently looking beyond short-term relief. Our focus now is on improving the long-term outlook, helping patients stay well, avoid complications, and live their lives with more confidence.”

Alongside advances in clinical practice, there is a growing recognition of the need to improve patient understanding of diagnostic procedures such as endoscopy. Patient advocates and healthcare professionals note that people living with IBD often leave consultations without fully understanding what their test results mean, making it harder to engage confidently in decisions about longterm care. Educational resources developed in collaboration with international patient organizations are aiming to close this gap by helping patients better understand clinical language and what different outcomes mean for their everyday lives.

In recent years, the UAE has placed a stronger spotlight on digestive health. Hospitals are building multidisciplinary care models that bring together gastroenterologists, dietitians, nurses, and mental health specialists, so patients receive support on every level. National awareness efforts are also helping people recognize the early signs of IBD and encouraging them to seek medical advice sooner.

Reflecting on the importance of awareness and education, Pedro Mato Rosa, Managing Director of Johnson & Johnson Innovative Medicine, Gulf, said: “The UAE continues to place strong emphasis on strengthening digestive health and long-term disease prevention. Greater awareness, timely diagnosis and clear understanding of conditions like IBD are critical to improving outcomes. At Johnson & Johnson, we are committed to being a long-term partner to the healthcare community, supporting research, education and collaborations that help build resilient, patient-centered healthcare systems.”

Looking Ahead

A more open conversation about gut health will make a real difference. Talking openly about symptoms can reduce stigma and help people reach a diagnosis earlier. At the same time, continued investment in research, education and patient support promises to improve outcomes for patients across the country.

As the UAE strengthens its healthcare system, the story of IBD reflects both progress and hope. With greater awareness, earlier diagnosis, and evolving approaches to care, patients can look forward to healthier, more confident lives, and the country is showing how care for digestive health can help set new standards for the future.

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10197139/
  2. https://www.hopkinsmedicine.org/health/conditions-and-diseases/inflammatory-bowel-disease
  3. https://www.sciencedirect.com/science/article/pii/S2468125323001930
  4. https://www.hopkinsmedicine.org/health/conditions-and-diseases/inflammatory-bowel-disease
  5.  Ahmed HA, Alzaabi MN, Swaid TK, et al. Evolving clinical burden of inflammatory bowel disease in the United Arab Emirates: a two-decade analysis of diagnoses and disease severity. Frontline Gastroenterology. Published online 2025
  6. https://ibduae.ae/about-ibd/
  7.  Yzet C, et al. Endoscopic healing and long-term outcomes in inflammatory bowel disease. Journal of Crohn’s and Colitis, 2025

Related Articles

Back to top button